XML 184 R23.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Fair Value
12 Months Ended
Dec. 28, 2019
Fair Value Disclosures [Abstract]  
Fair Value [Text Block]
NOTE 15 :
FAIR VALUE

ASSETS AND LIABILITIES MEASURED AND RECORDED AT FAIR VALUE ON A RECURRING BASIS
 
 
December 28, 2019
 
December 29, 2018
 
 
Fair Value Measured and
Recorded at Reporting Date Using
 
Total
 
Fair Value Measured and
Recorded at Reporting Date Using
 
Total
(In Millions)
 
Level 1
 
Level 2
 
Level 3
 
Level 1
 
Level 2
 
Level 3
 
Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash equivalents:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
 
$

 
$
713

 
$

 
$
713

 
$

 
$
262

 
$

 
$
262

Financial institution instruments1
 
1,064

 
408

 

 
1,472

 
550

 
183

 

 
733

Reverse repurchase agreements
 

 
1,500

 

 
1,500

 

 
1,850

 

 
1,850

Short-term investments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
 

 
347

 

 
347

 

 
937

 

 
937

Financial institution instruments1
 

 
724

 

 
724

 

 
1,423

 

 
1,423

Government debt2
 

 
11

 

 
11

 

 
428

 

 
428

Trading assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
 

 
2,848

 

 
2,848

 

 
2,635

 

 
2,635

Financial institution instruments1
 
87

 
1,578

 

 
1,665

 
67

 
1,273

 

 
1,340

Government debt2
 

 
3,334

 

 
3,334

 

 
1,868

 

 
1,868

Other current assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivative assets
 
50

 
230

 

 
280

 

 
180

 

 
180

Loans receivable3
 

 

 

 

 

 
354

 

 
354

Marketable equity securities
 
450

 

 

 
450

 
1,440

 

 

 
1,440

Other long-term investments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
 

 
1,898

 

 
1,898

 

 
1,843

 

 
1,843

Financial institution instruments1
 

 
825

 

 
825

 

 
912

 

 
912

Government debt2
 

 
553

 

 
553

 

 
633

 

 
633

Other long-term assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivative assets
 

 
690

 
16

 
706

 

 
100

 

 
100

Loans receivable3
 

 
554

 

 
554

 

 
229

 

 
229

Total assets measured and recorded at fair value
 
$
1,651

 
$
16,213

 
$
16

 
$
17,880

 
$
2,057

 
$
15,110

 
$

 
$
17,167

Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other accrued liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivative liabilities
 
$
3

 
$
287

 
$

 
$
290

 
$

 
$
412

 
$

 
$
412

Other long-term liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivative liabilities
 

 
13

 

 
13

 

 
415

 
68

 
483

Total liabilities measured and recorded at fair value
 
$
3

 
$
300

 
$

 
$
303

 
$

 
$
827

 
$
68

 
$
895


1 
Level 1 investments in financial institution instruments consist of money market funds. Level 2 investments consist primarily of commercial paper, certificates of deposit, time deposits, and notes and bonds issued by financial institutions.
2 
Level 2 investments in government debt consist primarily of U.S. agency notes and non-U.S. government debt.
3 
The fair value of our loans receivable for which we elected the fair value option did not significantly differ from the contractual principal balance based on the contractual currency.


ASSETS MEASURED AND RECORDED AT FAIR VALUE ON A NON-RECURRING BASIS
Our non-marketable equity securities, equity method investments, and certain non-financial assets, such as intangible assets and property, plant and equipment, are recorded at fair value only if an impairment or observable price adjustment is recognized in the current period. If an impairment or observable price adjustment is recognized on our non-marketable equity securities during the period, we classify these assets as Level 3 within the fair value hierarchy based on the nature of the fair value inputs.
We classified non-marketable equity securities and non-marketable equity method investments as Level 3. Impairments recognized on these investments held as of December 28, 2019 were $113 million ($416 million held as of December 29, 2018 and $537 million held as of December 30, 2017).
FINANCIAL INSTRUMENTS NOT RECORDED AT FAIR VALUE ON A RECURRING BASIS
Financial instruments not recorded at fair value on a recurring basis include non-marketable equity securities and equity method investments that have not been remeasured or impaired in the current period, grants receivable, loans receivable, reverse repurchase agreements, and our short-term and long-term debt.
As of December 28, 2019, the aggregate carrying value of grants receivable, loans receivable, and reverse repurchase agreements was $543 million (the aggregate carrying amount as of December 29, 2018 was $833 million). The estimated fair value of these financial instruments approximates their carrying value and is categorized as Level 2 within the fair value hierarchy based on the nature of the fair value inputs.